Achieve Life Sciences Announces Granting of New Hire Inducement Award
17 mars 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 17, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development...
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2022 and Provides Corporate Update
16 mars 2023 16h05 HE
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 16, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Substance Abuse Treatment Global Market Report 2023: Sector to Grow by 8.65% Annually Through 2033 With Rising Public Awareness and Increasing Drug Misuse Boosting Sector
16 mars 2023 07h33 HE
|
Research and Markets
Dublin, March 16, 2023 (GLOBE NEWSWIRE) -- The "Substance Abuse Treatment Market Report by Treatment Type, by End-use, and by Region - Global Forecast to 2022-2033" report has been added to ...
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
08 mars 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 08, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
03 mars 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash. and VANCOUVER, British Columbia, March 03, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023
02 mars 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
07 févr. 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
02 févr. 2023 08h00 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global...
Achieve Life Sciences Announces Granting of New Hire Inducement Award
27 janv. 2023 16h30 HE
|
Achieve Life Sciences
SEATTLE, Wash and VANCOUVER, British Columbia, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development...
Synergy Life Science Releases Nebi, a Groundbreaking, Portable Nebulizer
25 janv. 2023 09h30 HE
|
Synergy Life Science
BUFORD, Ga. , Jan. 25, 2023 (GLOBE NEWSWIRE) -- Synergy Life Science, Inc. (“Synergy”), a company pioneering the development of novel ingredients and innovative products for the consumer health and...